Adalimumab and Crohn's disease; A long-term real world experience

被引:0
|
作者
Iqbal, J. [1 ]
Kemp, K. [1 ]
Hodgins, J. [1 ]
Chan, L. [1 ]
Willert, R. [1 ]
Makin, A. [1 ]
Campbell, S. [1 ]
机构
[1] Manchester Royal Infirm, Dept Gastroenterol, Manchester M13 9WL, Lancs, England
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A88 / A88
页数:1
相关论文
共 50 条
  • [31] Long-term real-world data of ustekinumab in Crohn's Disease - the Stockholm ustekinumab study - STOCUSTE
    Bello, F.
    Lordal, M.
    Johansson, F.
    Sabhan, H.
    Muhsen, S.
    Borin, A.
    Forsberg, O.
    Wennerstrom, C.
    Soderman, C.
    Almer, S.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I130 - I131
  • [32] Real-world long-term effectiveness of ustekinumab in Crohn's disease: Results from the ENEIDA registry
    Iborra Colomino, M. I.
    Beltran, B.
    Fernandez-Clotet, A.
    Iglesias Flores, E.
    Navarro, P.
    Rivero, M.
    Gutierrez, A.
    Sierra-Ausin, M.
    Mesonero, F.
    Ferreiro-Iglesias, R.
    Hinojosa, J.
    Calvet, X.
    Sicilia, B.
    Gonzalez-Munoza, C.
    Antolin, B.
    Gonzalez Vivo, M.
    Carbajo, A. Y.
    Garcia, S.
    Martin-Cardona, A.
    Suris Marin, G.
    Martin-Arranz, M. D.
    De Francisco, R.
    Canete, F.
    Carlos, T.
    Gomollon, F.
    Lorente, R.
    Rodriguez-Lago, I.
    Fores-Bosch, A.
    Bernardos, E.
    Ramos, L.
    Delgado, P.
    Hernandez, A.
    Van Domselaar, M.
    Hervas, D.
    Domenech, E.
    Nos, P.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S458 - S460
  • [33] Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study
    Chaparro, Maria
    Baston-Rey, Iria
    Fernandez-Salgado, Estela
    Gonzalez Garcia, Javier
    Ramos, Laura
    Diz-Lois Palomares, Maria Teresa
    Arguelles-Arias, Federico
    Iglesias Flores, Eva
    Cabello, Mercedes
    Rubio Iturria, Saioa
    Nunez Ortiz, Andrea
    Charro, Mara
    Ginard, Daniel
    Duenas Sadornil, Carmen
    Merino Ochoa, Olga
    Busquets, David
    Iyo, Eduardo
    Gutierrez Casbas, Ana
    Ramirez de la Piscina, Patricia
    Maia Bosca-Watts, Marta
    Arroyo, Maite
    Jose Garcia, Maria
    Hinojosa, Esther
    Gordillo, Jordi
    Martinez Montiel, Pilar
    Velayos Jimenez, Benito
    Quilez Ivorra, Cristina
    Vazquez Moron, Juan Maria
    Maria Huguet, Jose
    Gonzalez-Lama, Yago
    Munagorri Santos, Ana Isabel
    Manuel Amo, Victor
    Dolores Martin-Arranz, Maria
    Bermejo, Fernando
    Martinez Cadilla, Jesus
    Rubin de Celix, Cristina
    Fradejas Salazar, Paola
    Lopez San Roman, Antonio
    Jimenez, Nuria
    Garcia Lopez, Santiago
    Figuerola, Anna
    Jimenez, Itxaso
    Martinez Cerezo, Francisco Jose
    Taxonera, Carlos
    Varela, Pilar
    de Francisco, Ruth
    Monfort, David
    Molina Arriero, Gema
    Hernandez Camba, Alejandro
    Javier Garcia-Alonso, Francisco
    INFLAMMATORY BOWEL DISEASES, 2022, 28 (11) : 1725 - 1736
  • [34] REAL-WORLD LONG-TERM EFFECTIVENESS OF USTEKINUMAB IN CROHN'S DISEASE: RESULTS FROM THE ENEIDA REGISTRY
    Iborra, Marisa
    Beltran, Belen
    Fernandez-Clotet, Agnes
    Flores, Eva Iglesias
    Cortes, Pablo Navarro
    Rivero, Montserrat
    Gutierrez, Ana
    Sierra-Ausin, Monica
    Mesonero, Francisco
    Ferreiro, Rocio
    Hinojosa, Joaquin
    Calvet, Xavier
    Sicilia, Beatriz
    Gonzalez-Munosa, Carlos
    Antolin, Beatriz
    Gonzalez, Maria
    Lopez, Ana Y. Carbajo
    Garcia-Lopez, Santiago
    Cardona, Albert Martin
    Suris, Gerard
    Arranz, Maria Dolores A. Martin
    De Francisco, Ruth M.
    Canete, Fiorella
    Samso, Carlos Taxonera
    Gomollon, Fernando
    Lorente, Rufo
    Rodriguez-Lago, Iago
    Fores-Bosh, Ana
    Bernardos, Esther
    Ramos, Laura
    Delgado-Guillena, Pedro
    Camba, Alejandro Hernandez
    Van Domselaar, Manuel
    Hervas, David
    Domenech, Eugeni
    Nos, Pilar
    GASTROENTEROLOGY, 2020, 158 (06) : S953 - S953
  • [35] Long-term real life efficacy of infliximab in Crohn's disease: Brazilian initial experience since 1999
    Arceu, Scanavini Neto
    Natalia, Queiroz
    Marcelo, Borba
    Carlos, Sobrado
    Magaly, Teixeira
    Edesio, Silva-Fillho
    Sergio, Nahas
    Ivan, Cecconello
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S4 - S4
  • [36] Short and long-term results of adalimumab treatment of patients with active Crohn's disease: Experience of a Greek single center for inflammatory bowel disease
    Triantafillidis, J. K.
    Fouskas, J.
    Malgarinos, G.
    Malli, Ch.
    Gikas, A.
    Mylonaki, M.
    Georgopoulos, F.
    Panteris, V.
    Cheracakis, P.
    ANNALS OF GASTROENTEROLOGY, 2009, 22 (03): : 168 - 172
  • [37] Long-term clinical and real-world experience with Crohn's disease treated with anti-tumor necrosis factor-α antibodies
    Otake, Haruka
    Matsumoto, Satohiro
    Mashima, Hirosato
    INTESTINAL RESEARCH, 2022, 20 (04) : 464 - 474
  • [38] Long-term treatment of Crohn's disease
    Lichtenstein, GR
    INFLAMMATORY BOWEL DISEASES, 2004, 10 : S1 - S1
  • [39] Long-Term Outcomes After Institution of Adalimumab Therapy in Pediatric Crohn Disease
    Rosh, Joel R.
    Lerer, Trudy
    Stephens, Michael C.
    Carvalho, Ryan
    Pfefferkorn, Marian D.
    Evans, Jonathan
    Griffiths, Anne M.
    Otley, Anthony R.
    Bousvaros, Athos
    Grossman, Andrew B.
    Ashai-Khan, Farhat N.
    Leleiko, Neal S.
    Keljo, David J.
    Kay, Marsha H.
    Hitch, Meredith C.
    Saeed, Shehzad A.
    Oliva-Hemker, Maria
    Mack, David R.
    Markowitz, James
    Hyams, Jeffrey S.
    GASTROENTEROLOGY, 2012, 142 (05) : S36 - S36
  • [40] Buruli (Bairnsdale) ulcer in the setting of long-term adalimumab treatment for Crohn disease
    Freckelton, Julia
    Holt, Darcy
    Sandhu, Manjeet
    Prideaux, Lani
    Moore, Gregory T.
    INTERNAL MEDICINE JOURNAL, 2018, 48 (05) : 603 - +